?Therapeutic considerationsPregnancy doxazosin mesyl ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , doxazosin mesyl an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the.

a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used doxazosin mesyl treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form doxazosin mesyl doxazosin, to be marketed doxazosin mesyl Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It doxazosin mesyl doxazosin mesyl alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to doxazosin mesyl marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine doxazosin mesyl alpha doxazosin mesyl in the doxazosin mesyl nervous system. The primary.

of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker doxazosin mesyl to treat high blood pressure and benign.